Nuclear Medicine Market Dynamics, Future Insights, Share Value, Growth Outlook, COVID-19 Impact and Size Projection By 2027
Nuclear Medicine Market Overview
Nuclear
medicine market offers precise diagnostic abilities and is
useful in the early detection of cancer as well as other diseases such as
cardiovascular disorders. The increasing prevalence of cancer and other chronic
diseases and a high demand for early diagnosis of such diseases for effective
treatment is a significant driver of the global market. Moreover, increasingly
radiopharmaceuticals are being used for the diagnosis or treatment of chronic
diseases in geriatric patients. The rapid expansion of this demographic is
expected to encourage the growth of the market. The WHO has recorded astounding
figures regarding the prevalence of cancer at nearly one out of every six
deaths, making it one of the most significant causes for patient mortality,
thus increasing the demand for nuclear medicine.
The promising
future of the global nuclear medicine market is threatened by the high costs of
radiopharmaceuticals which makes treatment unaffordable. Although it has not
been proven to be distinctly harmful, erring on the side of safety has made
patients wary of adopting nuclear medicine due to the side effects associated
with exposure to radiation. However, market opportunities are expected to
mitigate these threats to growth. Radioisotopes are witnessing increased usage
for diagnostics and therapeutics as they offer the potential for learning
medical information that is otherwise unobtainable. They have a wide range of
applications in medical research which range from observing metabolic processes
to tracing drug movement in biological systems.
MRFR has conducted a
detailed study of the various parts of the nuclear medicine market which has been segmented based on product type,
application, end-user, and region. By product types, the nuclear medicine
market has been segmented into diagnostic nuclear medicine and therapeutic
radiopharmaceuticals. At present, the diagnostic nuclear medicine segment has
attained a leadership position. However, the therapeutic radiopharmaceuticals
segment is the fastest growing segment during the forecast period. The
diagnostic nuclear medicine segment is segmented further into SPECT
radiopharmaceuticals, and PET radiopharmaceuticals. Meanwhile, the therapeutic
radiopharmaceuticals segment is sub-segmented into alpha emitters, beta
emitters, and brachytherapy isotopes.
Applications of nuclear
medicine are segmented into diagnostic applications and therapeutic
applications. Diagnostic applications are a major segment which is
sub-segmented into SPECT applications and PET applications. Meanwhile, the
therapeutic applications segment is growing at the fastest pace.
End-users have been
segmented into hospitals & diagnostic centres, research institutes, and
others. Research institutes display the highest potential for growth over the
forecast period, while hospitals & diagnostics centres have been identified
as the most significant segment in terms of nuclear
medicine market share.
All sub-segments have been segmented further and
included in the report.
Regional Analysis
The Americas due to the presence of North America
has established itself as a market leader. The presence of several important
market players combined with the high prevalence of cancer and other chronic
diseases has influenced the growth of the Americas nuclear market. The region,
particularly countries such as U.S & Canada have well-developed healthcare
sectors which receive high investments. Moreover, the region has a high
geriatric patient population which is expanding rapidly and is growing
increasingly aware regarding advanced therapies.
Key Players
Nuclear Medicine Market player report include
Jubilant Lifesciences, Lantheus Medical Imaging, Mallinckrodt Pharmaceuticals,
Medtronic plc, Bayer AG, Advanced Accelerators Applications, Nordion Inc.,
Cardinal Health, Bracco Imaging, Curium, and GE Healthcare.
About
Market Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment